Evidence map›Paper›PMID 39459457›Full record

ArticleMedicina (Kaunas, Lithuania)2024

The Impact of Infliximab on Hyperinflammation State in Hospitalized COVID-19 Patients: A Retrospective Study.

Yasmine M Saied, Ahmed Essam Abou Warda, Rasha Mahmoud Allam, Wajid Syed, Mahmood Basil A Al-Rawi, Ayesha Iqbal, Marwa O Elgendy, Ramy M El-Sabaa, Ahmed Hassan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yasmine M SaiedMicrobiology and Immunology Postgraduate Program, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.ORCID 0000-0002-3106-0415
Ahmed Essam Abou WardaClinical Pharmacy Department, Faculty of Pharmacy, October 6 University, Giza 12585, Egypt.ORCID 0000-0003-4434-6217
Rasha Mahmoud AllamCancer Epidemiology and Biostatistics, National Cancer Institute, Cairo University, Cairo 11796, Egypt.
Wajid SyedDepartment of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-4077-4524
Mahmood Basil A Al-RawiDepartment of Optometry, College of Applied Medical Sciences, King Saud University, Riyadh 11451, Saudi Arabia.
Ayesha IqbalDepartment of Pharmacy Practice and Policy, University Park Campus, University of Nottingham, Nottingham NG7 2QL, UK.ORCID 0000-0001-7282-471X
Marwa O ElgendyDepartment of Clinical Pharmacy, Beni-Suef University Hospitals, Beni-Suef University, Beni-Suef 62521, Egypt.ORCID 0000-0002-5466-0552
Ramy M El-SabaaClinical Pharmacy Department, Faculty of Pharmacy, Menoufia University, Menoufia 32511, Egypt.
Ahmed HassanClinical Pharmacy Department, Faculty of Pharmacy, University of Sadat City, Menoufia 32897, Egypt.ORCID 0000-0003-0078-0310

Funding

King Saud University (RSP2024R378)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19COVID-19 Drug TreatmentInfliximabAdultAgedFemaleHospitalizationHumansInflammationMaleMiddle AgedRetrospective StudiesSARS-CoV-2Treatment OutcomeInfliximabCOVID-19infliximabpro-inflammatory cytokinesstandard of care

Identifiers

PMID39459457
PMCPMC11509666

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.